Compare Lufax Holding Ltd (LU) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lufax Holding Ltd vs State Street SPDR S&P Biotech ETF — how do they compare? Lufax Holding Ltd trades at $1.4 (market cap $2.41B), while State Street SPDR S&P Biotech ETF trades at $154.43. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Lufax Holding Ltd nearer its low. Which is the better fit depends on your goals.
| LU | XBI | |
|---|---|---|
Market Cap | $2.41B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $4.40 | $164.28 |
52-Week Low | $1.23 | $85.16 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lufax Holding Ltd
Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.
Read more on LU →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
